Table 3.
Results of renal biopsy in nondiabetic nephropathy⁎
| Pathology | Total (n=65) | A | B | C | D | E |
|---|---|---|---|---|---|---|
| MN | 15 (23.1) | 8 (53.3) | 5 (33.3) | 0 (0) | 1 (6.7) | 1 (6.7) |
| IgA nephropathy | 14 (21.5) | 6 (42.9) | 3 (21.4) | 3 (21.4) | 2 (14.3) | 0 (0) |
| ATIN | 10 (15.4) | 4 (40.0) | 1 (10.0) | 4 (40.0) | 1 (10.0) | 0 (0) |
| FSGS | 6 (9.2) | 3 (50.0) | 1 (16.7) | 2 (33.3) | 0 (0) | 0 (0) |
| MCD | 5 (7.7) | 1 (20.0) | 2 (40.0) | 1 (20.0) | 1 (20.0) | 0 (0) |
| HSP nephritis | 4 (6.2) | 2 (50.0) | 0 (0) | 1 (25.0) | 1 (25.0) | 0 (0) |
| DPGN | 3 (4.6) | 1 (33.3) | 1 (33.3) | 0 (0) | 1 (33.3) | 0 (0) |
| MesPGN | 2 (3.1) | 1 (50.0) | 0 (0) | 0 (0) | 1 (50.0) | 0 (0) |
| ANCA-GN | 2 (3.1) | 0 (0) | 0 (0) | 2 (100.0) | 0 (0) | 0 (0) |
| HT nephropathy | 2 (3.1) | 0 (0) | 0 (0) | 1 (50.0) | 1 (50.0) | 0 (0) |
| MPGN | 1 (1.5) | 1 (100.0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| IgM nephropathy | 1 (1.5) | 1 (100.0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Data are presented as n (%).
ATIN, acute tubulointerstitial nephritis; DPGN, diffuse proliferative glomerulonephritis; FSGS, focal segmental glomerulosclerosis; GN, glomerulonephritis; HSP, Henoch–Schönlein purpura; HT, hypertensive; MCD, minimal change disorder; MesPGN, mesangial proliferative glomerulonephritis; MN, membranous nephropathy; MPGN, membranous proliferative glomerulonephritis.
A, Nephrotic range proteinuria (>3 g/day) with atypical course; B, Proteinuria without diabetic retinopathy [urine total protein (TP)>500 mg/day or spot urine TP/Cr>500 mg/g]; C, Unexplained decline of renal function; D, Unexplained hematuria (>3 red blood cells/high-power field); E, Proteinuria with short duration of diabetes (24 h urine TP>500 mg or spot urine TP/creatinine >500 mg/g within 5 years of diabetes).